tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Bristol Myers commitment a reminder of Veeva’s progress, says Stifel
PremiumThe FlyBristol Myers commitment a reminder of Veeva’s progress, says Stifel
1M ago
Bayer announces progress for two potential therapies for Parkinson’s disease
Premium
The Fly
Bayer announces progress for two potential therapies for Parkinson’s disease
1M ago
Oppenheimer maintains bullish stance on Corteva following split reports
Premium
The Fly
Oppenheimer maintains bullish stance on Corteva following split reports
2M ago
Bayer’s New Clinical Study on HER2-Targeted Cancer Treatment: A Potential Game Changer
PremiumCompany AnnouncementsBayer’s New Clinical Study on HER2-Targeted Cancer Treatment: A Potential Game Changer
3M ago
Bayer AG’s Exploratory Study on Sepsis and DIC: A Potential Game Changer?
Premium
Company Announcements
Bayer AG’s Exploratory Study on Sepsis and DIC: A Potential Game Changer?
3M ago
Bayer AG’s Innovative Phase I Study: A New Frontier in Cancer Treatment
Premium
Company Announcements
Bayer AG’s Innovative Phase I Study: A New Frontier in Cancer Treatment
3M ago
Bayer’s Phase 2 Study on BAY2927088: A Potential Game-Changer in HER2-Positive Tumor Treatment
PremiumCompany AnnouncementsBayer’s Phase 2 Study on BAY2927088: A Potential Game-Changer in HER2-Positive Tumor Treatment
3M ago
Bayer AG’s Regorafenib Study: A Potential Game-Changer in Cancer Treatment
Premium
Company Announcements
Bayer AG’s Regorafenib Study: A Potential Game-Changer in Cancer Treatment
3M ago
Bayer AG Advances Parkinson’s Treatment with Promising Gene Therapy Study
Premium
Company Announcements
Bayer AG Advances Parkinson’s Treatment with Promising Gene Therapy Study
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100